Literature DB >> 28579226

Reprising the role of CD4 cell count in HIV programmes.

Rosanna W Peeling1, Nathan Ford2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28579226     DOI： 10.1016/S2352-3018(17)30096-6

Source DB:  PubMed          Journal:  Lancet HIV        ISSN： 2352-3018            Impact factor:   12.767


× No keyword cloud information.
  5 in total

Review 1.  Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response.

Authors:  Paul K Drain; Jienchi Dorward; Andrew Bender; Lorraine Lillis; Francesco Marinucci; Jilian Sacks; Anna Bershteyn; David S Boyle; Jonathan D Posner; Nigel Garrett
Journal:  Clin Microbiol Rev       Date:  2019-05-15       Impact factor: 26.132

2.  Point-of-care CD4 testing: Differentiated care for the most vulnerable.

Authors:  Elizabeth Spooner; Tarylee Reddy; Nobuhle Mchunu; Shabashini Reddy; Brodie Daniels; Noluthando Ngomane; Nozipho Luthuli; Photini Kiepiela; Anna Coutsoudis
Journal:  J Glob Health       Date:  2022-02-05       Impact factor: 4.413

3.  Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV.

Authors:  Oliver T Stirrup; Caroline A Sabin; Andrew N Phillips; Ian Williams; Duncan Churchill; Anna Tostevin; Teresa Hill; David T Dunn
Journal:  J Virus Erad       Date:  2019-11-04

4.  Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.

Authors:  T B Leeme; M Mine; K Lechiile; F Mulenga; M Mosepele; T Mphoyakgosi; C Muthoga; J Ngidi; B Nkomo; D Ramaabya; M Tau; M W Tenforde; R Hayes; J N Jarvis
Journal:  HIV Med       Date:  2020-09-02       Impact factor: 3.094

5.  Effects of National Adoption of Treat-All Guidelines on Pre-Antiretroviral Therapy (ART) CD4 Testing and Viral Load Monitoring After ART initiation: A Regression Discontinuity Analysis.

Authors:  Ellen Brazier; Olga Tymejczyk; Elizabeth Zaniewski; Matthias Egger; Kara Wools-Kaloustian; Constantin T Yiannoutsos; Antoine Jaquet; Keri N Althoff; Jennifer S Lee; Yanink Caro-Vega; Paula M Luz; Junko Tanuma; Théodore Niyongabo; Denis Nash
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.